Concepedia

Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinase

Luca Mologni, Alexandre Orsato, Alfonso Zambon, Sébastien Tardy, William H. Bisson, Cédric Schneider, Monica Ceccon, Michela Viltadi, Joseph D’Attoma, Sara Pannilunghi,

European Journal of Medicinal Chemistry · 2022 · 12 citations · 11 references

DOIFull text

Open access

Concepts

References

11

Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase–Positive Lymphoma Patients

Carlo Gambacorti‐Passerini, Francesca Farina, Alessandra Stasia et al. · JNCI Journal of the National Cancer Institute · 2014 · 279 citations

, , +16

Tracking the Evolution of Resistance to ALK Tyrosine Kinase Inhibitors Through Longitudinal Analysis of Circulating Tumor DNA

Ibiayi Dagogo‐Jack, A. Rose Brannon, Lorin A. Ferris et al. · JCO Precision Oncology · 2018 · 131 citations · Full text

, , +17

Three novel patient‐derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors

Sara Redaelli, Luca Mologni, Roberta Rostagno et al. · American Journal of Hematology · 2012 · 111 citations

, , +13

Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer

Sara Redaelli, Monica Ceccon, Marina Zappa et al. · Cancer Research · 2018 · 90 citations · Full text

, , +16

Crizotinib-Resistant NPM-ALK Mutants Confer Differential Sensitivity to Unrelated Alk Inhibitors

Monica Ceccon, Luca Mologni, William H. Bisson et al. · Molecular Cancer Research · 2012 · 88 citations

, , +17